ESR1 and breast carcinoma: In the presence of Tx (a selective estrogen receptor modulator (SERM), the proliferation of MCF-7 breast cancer cells was reduced (−50%) (Figure 1A,B), corresponding to expected results since the half-maximal inhibitory concentration was used (IC50 = 10 μM) as in our previous experiments [18].